Cargando…

Performance of the Human Papillomavirus E6/E7 mRNA Assay in the Primary Screening of Cervical Cancer: Opportunistic Screening in Fujian, China

PURPOSE: A high-risk human papillomavirus E6/E7 mRNA (HR-HPV mRNA) assay is widely used in cervical cancer screening in China. However, it is still unclear whether stand-alone HR-HPV mRNA testing is sufficient for primary screening. The purpose of this study was to investigate the feasibility of a s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Lijuan, Weng, Xiulan, Wang, Lihua, Xie, Xiaoyan, Zhong, Liying, Liu, Dabin, Xiu, Yingling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617522/ https://www.ncbi.nlm.nih.gov/pubmed/36317009 http://dx.doi.org/10.2147/IJWH.S383431

Ejemplares similares

Assessment of High-Risk Human Papillomavirus Infection Characteristics in Cervical Squamous Cell Carcinoma and Adenocarcinoma in China
por: Zhuang, Lijuan, et al.
Publicado: (2022)

Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China
por: Ruan, Guanyu, et al.
Publicado: (2018)

Performance of human papillomavirus E6/E7 mRNA assay for primary cervical cancer screening and triage: Population-based screening in China
por: Zhang, Jing, et al.
Publicado: (2022)

Screening of Some Indicators for Alpha-Thalassemia in Fujian Province of Southern China
por: Zheng, Lin, et al.
Publicado: (2021)

Novel In Situ Hybridization Assay for Chromogenic Single-Molecule Detection of Human Papillomavirus E6/E7 mRNA
por: Rao, Xuelian, et al.
Publicado: (2023)

Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening
por: Rebolj, Matejka, et al.
Publicado: (2014)

Analysis of the role of the human papillomavirus 16/18 E7 protein assay in screening for cervical intraepithelial neoplasia: a case control study
por: Kong, Linghua, et al.
Publicado: (2020)

Activity of Xenoestrogens at Nanomolar Concentrations in the E-Screen Assay
por: Silva, Elisabete, et al.
Publicado: (2007)

Potential Role of E4 Protein in Human Papillomavirus Screening: a Review
por: Yajid, Aidy Irman, et al.
Publicado: (2017)

Opportunistic pathology-based screening for diabetes
por: Simpson, Aaron J, et al.
Publicado: (2013)

Opportunistic hearing screening in elderly inpatients
por: Ramdoo, Krishan, et al.
Publicado: (2014)

The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China
por: Zhang, Shao-Kai, et al.
Publicado: (2020)

Correction to: Analysis of the role of the human papillomavirus 16/18 E7 protein assay in screening for cervical intraepithelial neoplasia: a case control study
por: Kong, Linghua, et al.
Publicado: (2020)

Human papillomavirus infection maybe not associated with primary lung cancer in the Fujian population of China
por: He, Fei, et al.
Publicado: (2020)

An opportunistic pre-diabetes screening program offered with existing hypertension screening
por: IQBAL, M.T.
Publicado: (2013)

The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States
por: Wheeler, Cosette M, et al.
Publicado: (2014)

Opportunistic Screening Techniques for Analysis of CT Scans
por: Engelke, Klaus, et al.
Publicado: (2022)

Clinical validation of the Cervista(®) high-risk human papillomavirus test in Chinese women from Fujian province: a cross-sectional study
por: Mao, Xiaodan, et al.
Publicado: (2018)

Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above
por: Rebolj, Matejka, et al.
Publicado: (2016)

Human papillomavirus self‐sampling with mRNA testing benefits routine screening
por: Auvinen, Eeva, et al.
Publicado: (2022)

Health economic evaluation of an mRNA high-risk human papillomavirus (HR-HPV) assay versus a DNA HR-HPV assay for the proposed French cervical screening programme
por: Dombrowski, Caroline A., et al.
Publicado: (2022)

Human papillomavirus testing in cervical cancer screening
por: Franceschi, S, et al.
Publicado: (2005)

Opportunistic Screening for Ca PVU in Primary Health Care
por: Mircic, Seka
Publicado: (2012)

Socioeconomic Disparities in Cancer Screening: Organized versus Opportunistic
por: Cho, Young Gyu
Publicado: (2016)

Determination of withdrawal times in individualized opportunistic screening colonoscopies
por: Zhan, Qiang, et al.
Publicado: (2019)

Opportunistic Screening for Exposure to Bullying in the Pediatric Emergency Department
por: Seltzer, Marlene, et al.
Publicado: (2017)

Opportunistic Breast Cancer Education and Screening in Rural Honduras
por: Kennedy, Linda S., et al.
Publicado: (2016)

An efficient method that combines the ThinPrep cytologic test with E6/E7 mRNA testing for cervical cancer screening
por: Pan, Dan, et al.
Publicado: (2019)

Prognostic Value of DNA and mRNA E6/E7 of Human Papillomavirus in the Evolution of Cervical Intraepithelial Neoplasia Grade 2
por: Discacciati, Michelle G, et al.
Publicado: (2014)

Opportunistic cervical cancer screening of women visitors at a trade fair in India
por: Hariprasad, Roopa, et al.
Publicado: (2017)

Organised Versus Opportunistic Cervical Cancer Screening in Urban and Rural Regions of Lithuania
por: Paulauskiene, Justina, et al.
Publicado: (2019)

Abnormal Pap smear among pregnant women – Feasibility of opportunistic cervical screening()
por: Mukhtar, Nur Farihan, et al.
Publicado: (2023)

Breast cancer screening attendance in two Swiss regions dominated by opportunistic or organized screening
por: Eichholzer, Monika, et al.
Publicado: (2016)

The E-screen assay: a comparison of different MCF7 cell stocks.
por: Villalobos, M, et al.
Publicado: (1995)

Passive Radar for Opportunistic Monitoring in E-Health Applications
Publicado: (2018)

Human Papillomavirus DNA and E6/E7 mRNA Status in Relation to Survival of Patients Treated for Cervical Squamous Cell Carcinoma
por: Holm, Ruth, et al.
Publicado: (2008)

Efficiency of organised and opportunistic cytological screening for cancer in situ of the cervix.
por: Gustafsson, L., et al.
Publicado: (1995)

Opportunistic screening to detect atrial fibrillation in Aboriginal adults in Australia
por: Gwynne, Kylie, et al.
Publicado: (2016)

Assessing the capability of massively parallel sequencing for opportunistic pharmacogenetic screening
por: Ng, David, et al.
Publicado: (2016)

State of the Globe: Hepatitis C – Opportunistic versus Organized Screening
por: Raina, Sunil Kumar, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hg2eetp3m4debetnm3cr4qp6o4